Mira PharmaceuticalsMIRA
13F holders, Q1 2026 (March 31)26holders +1
4new positions
5sold out
$1.07avg. 13F price*
At the end of Q1 2026, 26 institutions reported holding Mira Pharmaceuticals Inc. (MIRA) in their 13F filings, up 1 from Q4 2025. 4 opened new positions and 5 sold out. The largest holders were Vanguard Capital Management LLC ($742K), Cross Staff Investments Inc ($385K) and Geode Capital Management, LLC ($311K).
- Company
- Mira Pharmaceuticals Inc.
- CUSIP
- 60458C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $55K |
| Exits | 5 | $581K |
All 13F filers, Q4 2025 → Q1 2026: 100,413 shares bought and 397,325 shares sold, net −296,912 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Vanguard Capital Management LLC | 0.00% | — | 693,912 | $742K |
| Cross Staff Investments Inc | 0.19% | No change | 359,401 | $385K |
| Geode Capital Management, LLC | 0.00% | Add +6.6% | 290,890 | $311K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 169,483 | $181K |
| BlackRock, Inc. | 0.00% | Add +2.4% | 112,346 | $120K |
| Suncoast Equity Management | 0.01% | Reduce -12.2% | 90,645 | $97K |
| Northern Trust Corp. | 0.00% | No change | 67,698 | $72K |
| First American Bank | 0.00% | No change | 60,000 | $64K |
| State Street Corp. | 0.00% | No change | 49,100 | $53K |
| XTX Topco Ltd | 0.00% | Add +79.7% | 37,573 | $40K |
| Commonwealth Equity Services, LLC | 0.00% | Add +16.2% | 35,067 | $38K |
| International Assets Investment Management, LLC | 0.00% | No change | 35,000 | $37K |
| Susquehanna International Group, LLP | 0.00% | New | 25,146 | $27K |
| Vanguard Global Advisers, LLC | 0.00% | — | 24,306 | $26K |
| Frec Markets, Inc. | 0.00% | New | 22,000 | $24K |
| Fifth Third Bancorp | 0.00% | No change | 20,000 | $21K |
| Mariner, LLC | 0.00% | No change | 16,500 | $18K |
| Cary Street Partners Financial LLC | 0.00% | No change | 10,000 | $11K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 8,000 | $9K |
| UBS Group AG | 0.00% | Add +139.1% | 6,456 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +171.9% | 4,976 | $5K |
| Citigroup Inc. | 0.00% | New | 4,226 | $5K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,000 | $2K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 2,000 | $2K |
| Wells Fargo & Company | 0.00% | No change | 23 | $25 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is MIRA's weight in each manager's 13F, not the share of Mira Pharmaceuticals Inc. the manager owns.